Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 15,048 | 17,488 | 19,559 | 22,978 | 23,401 |
| Operating Income | -15,048 | -17,488 | -19,559 | -22,978 | -23,401 |
| Other Income | 628 | 592 | 609 | 583 | 256 |
| Pre-tax Income | -14,420 | -16,896 | -18,950 | -22,395 | -23,145 |
| Net Income Continuous | -14,420 | -16,896 | -18,950 | -22,395 | -23,145 |
| Net Income | $-14,420 | $-16,896 | $-18,950 | $-22,395 | $-23,145 |
| EPS Basic Total Ops | -3.29 | -3.88 | -4.46 | -5.43 | -5.76 |
| EPS Basic Continuous Ops | -3.29 | -3.88 | -4.46 | -5.50 | -5.74 |
| EPS Diluted Total Ops | -3.29 | -3.88 | -4.46 | -5.43 | -5.76 |
| EPS Diluted Continuous Ops | -3.29 | -3.88 | -4.46 | -5.50 | -5.74 |
| EBITDA(a) | $-15,245 | $-17,531 | $-19,487 | $-22,933 | $-23,247 |